Physician profile
Lindsay Meadows
NPI 1437803343
$1,655.05
in general payments reported to CMS, 2019-2025
17 companies · $544 in 2025
The $544 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $396 · 2024: $715 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,655.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $344.63 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $225.27 | 2024 | Airsupra, Breztri |
| Novo Nordisk INC | $204.16 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $138.38 | 2023-2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Pfizer INC. | $133.72 | 2023-2025 | |
| Lilly USA, LLC | $107.65 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $97.98 | 2023-2025 | Repatha, Otezla, Otezla |
| Astellas Pharma US INC | $89.18 | 2023-2024 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $71.21 | 2023-2025 | Slynd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.03 | 2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.86 | 2023-2025 | Jardiance |
| Exact Sciences Corporation | $38.89 | 2024 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $37.01 | 2023 | Aptima |
| Organogenesis INC. | $27.86 | 2025 | Puraply Wound Matrix |
| Merck Sharp & Dohme LLC | $20.73 | 2023 | Belsomra, Steglatro |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $16.24 | 2025 | Licart, Flector, Tirosint |
| Renalytix Ai, INC. | $14.25 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsay Meadows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.